Dr. Kenneth Raymond King, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2101 Executive Dr, Tower Box 56, Hampton, VA 23666 Phone: 757-827-6298 Fax: 757-838-0725 |
News Archive
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
As people age, they progressively lose muscle mass and strength, and this can lead to frailty and other age-related diseases. As the causes for the decline remain largely unknown, promoting muscle health is an area of great research interest.
A team of researchers from Mount Sinai School of Medicine and four other institutions have found that young children with documented or likely allergies to milk and/or eggs, whose families were instructed on how to avoid these and other foods, still experienced allergic reactions at a rate of almost once per year. Of severe cases, less than a third received epinephrine, a medication used to counter anaphylaxis, a life-threatening allergic condition.
Aware, Inc., a global provider of imaging and biometrics software, today announced that it will introduce and demonstrate several new biometrics software products in its exhibition booth at the upcoming Biometrics Consortium Conference and Technology Expo. The event takes place in Tampa from September 21 to 23, 2010.
A UCLA-led study of HIV-positive women who were sexually abused as children has found that the more severe their past trauma, the greater their improvement in an intervention program designed to ease their psychological suffering.
› Verified 2 days ago